Papers

5

Total Citations

629

H-Index

4

About

Dr. Michael Feuerstein is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for urologic cancers, particularly bladder and prostate cancer. His most impactful contribution is the landmark randomized clinical trial comparing open radical cystectomy to robot-assisted laparoscopic radical cystectomy, which has garnered 596 citations and fundamentally shaped evidence-based practice in bladder cancer surgery. Dr. Feuerstein has also made significant contributions to understanding functional outcomes after robotic surgery, as demonstrated by his systematic review of robotic radical cystectomy outcomes, which critically evaluated urinary continence and sexual function recovery. His research extends to surgical innovation, including augmented reality for port placement in cardiovascular surgery and techniques for robotic prostatectomy in patients with prior prostate surgery. Notably, his work on self-assessment of surgical technique in partial nephrectomy highlights his commitment to quality improvement and reducing positive surgical margins. With a career dedicated to rigorous clinical trials and systematic reviews, Dr. Feuerstein has helped define modern standards for robotic urologic oncology, improving both oncologic control and patients' postoperative quality of life.

Research Focus

Key Achievements

4
H-Index
5
Papers
629
Total Citations
126
Avg Citations/Paper
🏆 Most Cited Paper
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial
596 citations · 2014
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Memorial Sloan Kettering Cancer Center, Technical University of Munich, Northwell Health, Lenox Hill Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago